Recent advances in colorectal cancer genetics and diagnostics

Critical Reviews in Oncology/Hematology

Volumn 69, Issue 1, 2009, Pages 45-55

  Cheah, Peh Yean ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Colorectal cancer diagnostics; Colorectal cancer genetics; Familial syndromes; Nuclear catenin; Sporadic colorectal cancer; Wnt TGF BMP LKB 1 PI3K AKT pathways

Indexed keywords

CANCER DIAGNOSIS; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; COLON POLYP; COLORECTAL CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; RECTUM POLYP; REVIEW;

ANIMALS; COLORECTAL NEOPLASMS; HUMANS; NEOPLASTIC SYNDROMES, HEREDITARY; SIGNAL TRANSDUCTION;

EID: 56449107092     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.08.001     Document Type: Review

References (140)

1. Kaz A.M., and Brentnall T.A. Genetic testing for colon cancer. Nat Clin Prac Gastrol Hepat 3 (2006) 670-679
2. Seow A, Koh WP, Chia KS, Shi LM, Lee HP, Shanmugaratnam KS. Trends in cancer incidence in Singapore 1968-2002. The Singapore Cancer Registry Report No. 6, 2004.
3. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
4. Cheah P.Y. Hypotheses for the etiology of colorectal cancer-an overview. Nutr Cancer 14 (1990) 5-13
5. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer-analysis of cohorts of twins from Sweden, Denmark and Finland. N Eng J Med 343 (2000) 78-85
6. Vasen H.F., Mecklin J.P., Khan P.M., and Lynch H.T. The international collaborative group on hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 34 (1991) 424-425
7. Vasen H.F., Watson P., Mecklin J.P., and Lynch H.T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 116 (1999) 1453-1456
8. Rodriguez-Bigas M.A., Boland C.R., Hamilton S.R., et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89 (1997) 1758-1762
9. Lynch H.T., Smyrk T., and Lynch J.F. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome). Int J Cancer 69 (1996) 38-43
10. Aaltonen L.A., Salovaara R., Kristo P., et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338 (1998) 1481-1487
11. Aaltonen L.A., Petlomaki P., Leach F., et al. Clues to the pathogenesis of familial colorectal cancer. Science 26 (1993) 812-816
12. Aaltonen L.A., Petlomaki P., Mecklin J.P., et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54 (1994) 1645-1648
13. Leach F.S., Nicolaides N.C., Papadopoulos N., et al. Mutation of a mut S homolog in hereditary nonpolyposis colorectal cancer. Cell 75 (1993) 1215-1225
14. Bronner C.E., Baker S.M., Morrison P.T., et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with HNPCC. Nature 368 (1994) 258-261
15. Papadopoulos N., Nidolaides N.C., Wei Y.F., et al. Mutation of a mut L homolog in hereditary colon cancer. Science 263 (1994) 1625-1629
16. Chung D.C., and Rustgi A.K. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 138 (2003) 560-570
17. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57 (1997) 808-811
18. Herman J.G., Umar A., Polyak K., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Nat Acad Sci USA 95 (1998) 6870-6875
19. Chan T.L., Yuen S.T., Kong C.K., et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 38 (2006) 1178-1183
20. Nicolaides N.C., Papadopoulos N., Liu B., et al. Mutations of two PMS homologues in hereditary nonpolyposis colorectal cancer. Nature 371 (1994) 75-80
21. Miyaki M., Konishi M., Tanaka K., et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17 (1997) 271-272
22. Akiyama Y., Sato H., Yamada T., et al. Germline mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 57 (1997) 3920-3923
23. Hendriks Y.M.C., Wagner A., Morreau H., et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127 (2004) 17-25
24. Mangold E., Pagenstecher C., Leister M., et al. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet 41 (2004) 567-572
25. South C.D., Hampel H., Comerars I., Westman J.A., Frankel W.L., and de la Chapelle A. The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst 100 (2008) 277-281
26. Groden J., Thliveris A., Samowitz W., et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66 (1991) 589-600
27. Joslyn G., Carlson N., Thliveris A., et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66 (1991) 600-613
28. Kinzler K.W., Nilbert M.C., Su L.K., et al. Identification of FAP locus genes from chromosome 5q21. Science 253 (1991) 661-665
29. Beroud C., and Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 24 (1996) 121-124
30. Cao X., Eu K.W., Seow-Choen F., Zhao Y., and Cheah P.Y. APC mutation and phenotypic spectrum of Singapore familial adenomatous polyposis patients. Eur J Hum Genet 8 (2000) 42-48
31. Sieber O.M., Lamlum H., Crabree M.D., et al. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas. Proc Natl Acad Sci USA 99 (2002) 2954-2958
32. De Rosa M., Dourisboure R.J., Morelli G., et al. First genotype characterization of Argentinean FAP patients: identification of 14 novel APC mutations. Hum Mut 23 (2004) 523-524
33. Michils G., Tejpar S., Thoelen R., et al. Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mut 25 (2005) 125-134
34. Aretz S., Stienen D., Uhlhaas S., et al. Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis. J Med Genet 42 (2005) 185-192
35. Galiatsatos P., and Foulkes W.D. Familial adenomatous polyposis. Am J Gastroenterol 101 (2006) 385-398
36. Cao X., Hong Y., Eu K.W., Loi C., and Cheah P.Y. Singapore familial adenomatous polyposis (FAP) patients with classical adenomatous polyposis but undetectable APC mutations have accelerated cancer progression. Am J Gastroenterol 101 (2006) 2810-2817
37. Friedl W., Caspari R., Sengteller M., et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48 (2001) 515-521
38. Nieuwenhuis M.H., and Vasen H.F.A. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol/Hematol 61 (2007) 153-161
39. Morin P.J., Sparks A.B., Korinek V., et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275 (1997) 1787-1790
40. Willert K., and Nusse R. β-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8 (1998) 95-102
41. Cao X., Eu K.W., Seow-Choen F., and Cheah P.Y. Germline mutations are frequent in the APC gene but absent in β-catenin gene in familial adenomatous polyposis patients. Genes Chromosomes Cancer 25 (1999) 396-398
42. Dobbie Z., and Muller H. Germline mutations in the β-catenin gene are not associated with the FAP phenotype without an APC mutation. J Med Genet 36 (1999) 573-574
43. Fodde R., Smits R., and Clever H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1 (2001) 55-67
44. Zbuk K.M., and Eng C. Hamartomatous polyposis syndromes. Nat Clin Prac Gastroenterol Hepatol 4 (2007) 492-501
45. Merg A., and Howe J.R. Genetic conditions associated with intestinal juvenile polyps. Am J Med Genet 129C (2004) 44-55
46. Howe J.R., Roth S., Ringold J.C., et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280 (1998) 1086-1088
47. Friedl W., Kruse R., Uhlhaas S., et al. Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients. Genes Chromosomes Cancer 25 (1999) 403-406
48. Woodford-Richens K., Williamson J., Bevan S., et al. Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium. Cancer Res 60 (2000) 2477-2482
49. Howe J.R., Bair J.L., Sayed M.G., et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28 (2001) 184-187
50. Zhou X., Woodford-Richens K., Lehtonen R., et al. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet 69 (2001) 704-711
51. Friedl W., Uhlhaas S., Schulmann K., et al. Juvenile polyposis:massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet 111 (2002) 108-111
52. Aretz S., Stienen D., Uhlhaas S., et al. High proportion of large genomic deletions and genotype-phenotype update in 80 unrelated families with Juvenile Polyposis syndrome. J Med Genet 44 (2007) 702-709
53. Sweet K., Willis J., Zhou X., et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 294 (2005) 2465-2473
54. Aretz S., Stienen D., Uhlhaas S., et al. High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mut 26 (2005) 513-519
55. Volikos E., Robinson J., Aittomaki K., et al. LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J Med Genet 43 (2006) e18
56. de Leng W.W., Jansen M., Carvalho R., et al. Genetic defects underlying Peutz-Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates. Clin Genet 72 (2007) 568-573
57. Liaw D., Marsh D.J., Li J., et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16 (1997) 64-67
58. Tang Y., and Eng C. PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner. Cancer Res 66 (2006) 736-742
59. Whitelaw S.C., Murday V.A., Tomlinson I.P., et al. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology 112 (1997) 327-334
60. Jaeger E.E.M., Woodford-Richens K.L., Lockett M., et al. An acenstral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet 72 (2003) 1261-1267
61. Jaeger E., Webb E., Howarth K., et al. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet 40 (2008) 26-28
62. Cao X., Eu K.W., Kumarasinghe M.P., Li H.H., Loi C., and Cheah P.Y. Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function. J Med Genet 43 (2006) e13
63. Ilyas M., Straub J., Tomlinson I.P.M., and Bodmer W.F. Genetic pathways in colorectal and other cancers. Eur J Cancer 35 (1999) 335-351
64. Al-Tassan N., Chmiel N.H., Maynard J., et al. Inherited variants of MYH associated with somatic G:C to T:A mutations in colorectal tumors. Nat Genet 30 (2002) 227-232
65. Sampson J.R., Dolwani S., Jones S., et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362 (2003) 39-41
66. Sieber O.M., Lipton L., Crabtree M., et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348 (2003) 791-799
67. Wang L., Baudhun L.M., Boardman L.A., et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 127 (2004) 9-16
68. Balaguer F., Castellvi-Bel S., Castells A., et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol 5 (2007) 379-387
69. Lipton L., Halford S.E., Johnson V., et al. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63 (2003) 7595-7599
70. Kambara T., Whitehall V.L., Spring K.J., et al. Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer 40 (2004) 1-9
71. Farrington S.M., Tenesa A., Barnetson R., et al. Germline susceptibility to colorectal cancer due to a base-excision repair gene defects. Am J Hum Genet 77 (2005) 112-119
72. Webb E.L., Rudd M.F., and Houlston R.S. Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet 79 (2006) 768-771
73. Young J., and Jass J.R. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 15 (2006) 1778-1784
74. Rustgi A.K. The genetics of hereditary colon cancer. Genes Dev 21 (2007) 2525-2538
75. Jass J.R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50 (2007) 113-130
76. Houlston R.S., and Tomlinson I.P.M. Polymorphisms and colorectal tumour risk. Gastroenterology 121 (2001) 282-301
77. Fearnhead N.S., Wilding J.L., Winney B., et al. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci USA 101 (2004) 15992-15997
78. Fearnhead N.S., Winney B., and Bodmer W.F. Rare variant hypothesis for multifactorial inheritance: susceptibility to colorectal adenomas as a model. Cell Cycle 4 (2005) 521-525
79. Bodmer W.F. Cancer genetics: colorectal cancer as a model. J Hum Genet 51 (2006) 391-396
80. Azzopardi D., Dallosso A.R., Eliason K., et al. Multiple rare nonsynonymus variants in the Adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res 68 (2008) 358-363
81. Pande M., Chen J., Amos C.I., Lynch P.M., Broaddus R., and Frazier M.L. Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population. Cancer Epidemiol biomarkers Prev 16 (2007) 1753-1759
82. Lima C.S., Nascimento H., Bonadia L.C., et al. Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma. Int J Colorectal Dis 22 (2007) 757-763
83. Kong S., Amos C.I., Luthra R., Lynch P.M., Levin B., and Frazier M.L. Effects of cyclin 1D polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 60 (2000) 249-252
84. Porter T.R., Richards F.M., Houlston R.S., et al. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 21 (2002) 1928-1933
85. Bala S., and Petlomaki P. Cyclin D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res 61 (2001) 6042-6045
86. Le Marchand L., Seifried A., Lum-Jones A., Donlon T., and Wilkens L.R. Association of the cylcin D1 A870G polymorphism with advanced colorectal cancer. JAMA 290 (2003) 2843-2848
87. Lewis R.C., Bostick R.M., Xie D., et al. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 63 (2003) 8549-8553
88. Hong Y., Eu K.W., Seow-Choen F., Fook-Chong S., and Cheah P.Y. The GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in Singapore patients. Eur J Cancer 41 (2005) 1037-1044
89. Kruger S., Engel C., Bier A., et al. Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett 236 (2006) 191-197
90. Talseth B.A., Ashton K.A., Meldrum C., et al. Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Int J Cancer 122 (2008) 1273-1277
91. Grunhage F., Jungck M., Lamberti C., et al. Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 23 (2008) 147-154
92. Tan X.L., Nieters A., Kropp S., Hoffmeister M., Brenner H., and Chang-Claude J. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis. Int J Cancer 122 (2008) 2573-2580
93. Haiman C.A., Le Marchand L., Yamamato J., et al. A common genetic risk factor for colorectal and prostate cancer. Nat Genet 39 (2007) 954-956
94. Tomlinson I., Webb W., Carvajal-Carmona L., et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39 (2007) 984-988
95. Zanke B.W., Greenwood C.M., Rangrej J., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39 (2007) 989-994
96. Broderick P., Carvajal-Carmona L., Pittman A.M., et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 39 (2007) 1315-1317
97. Tomlinson I.P.M., Webb E., Carvajal-Carmona L., et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 40 (2008) 623-630
98. Tenesa A., Farrington S.M., Prendergast J.G.D., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 40 (2008) 631-637
99. Miyoshi Y., Nagase H., Ando H., et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1 (1992) 229-233
100. Bienz M., and Clevers H. Linking colorectal cancer to Wnt signaling. Cell 103 (2000) 311-320
101. Chan T.L., Zhao W., Cancer Genome Project, Leung S.Y., and Yuen S.T. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63 (2003) 4878-4881
102. Spring K.J., Zhao Z.Z., Karamatic R., et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131 (2006) 1400-1407
103. Park S.J., Rashid A., Lee J.H., Kim S.G., Hamilton S.R., and Wu T.T. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162 (2003) 815-822
104. Halford S.E.R., Rowan A.J., Lipton L., et al. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 162 (2003) 1545-1548
105. Colebatch A., Hitchins M., Williams R., et al. The role of MYH and microsatellite instability in the development of sporadic colorectal cancer. Br J Cancer 95 (2006) 1239-1243
106. Koh W.P., Yuan J.M., Van Den Berg D., Ingles S.A., and Yu M.C. Peroxisome proliferator-activated receptor (PPAR)γ gene polymorphisms and colorectal cancer risk among Chinese in Singapore. Carcinogenesis 27 (2006) 1979-2802
107. Le Marchand L., Wilkens L.R., Kolonel L.N., and Henderson B.E. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14 (2005) 1198-1203
108. Ulrich C.M., Curtin K., Potter J.D., Bigler J., Caan B., and Slattery M.L. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 2509-2516
109. Martinez M.E., Thompson P., Jacobs E.T., et al. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway. Gastroenterology 131 (2006) 1706-1716
110. Huang Y., Han S., Li Y., Mao Y., and Xie Y. Different roles of MTHFR C677T and A1298C polymorhphisms in colorectal adenoma and colorectal cancer: a metaanalysis. J Hum Genet 52 (2007) 73-85
111. Curtin K., Slattery M.L., Ulrich C.M., et al. Genetic polymorhphisms in onecarbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28 (2007) 1672-1679
112. Probst-Hensch N.M., Sun C.L., Van Den Berg D., Ceschi M., Koh W.P., and Yu M.C. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in Singapore Chinese Health Study. Carcinogenesis 27 (2006) 2475-2482
113. Lai P.S., Cheah P.Y., Kadam P., et al. Overexpression of RB1 transcript is significantly correlated with 13q14 allelic imbalance in colorectal carcinomas. Int J Cancer 19 (2006) 1061-1066
114. Ullenhag G.J., Mukherjee A., Watson N.F., Al-Attar A.H., Scholefield J.H., and Durrant L.G. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients. Clin Cancer Res 13 (2007) 5070-5075
115. Spurling C.C., Godman C.A., Noonan E.J., Rasmussen T.P., Rosenberg D.W., and Giardina C. HDAC3 overexpression and colon cancer cell proliferation and differentiation. Mol Carcinog 47 (2008) 137-147
116. Zhao Z.R., Zhang Z.Y., Zhang H., Jiang L., Wang M.W., and Sun X.F. Overexpression of ID-1 protein is a marker in colorectal cancer progression. Oncol Rep 19 (2008) 419-424
117. Hong Y., Ho K.S., Eu K.W., and Cheah P.Y. A susceptibility gene-set for early onset colorectal cancer that integrates diverse signaling pathways-implication for tumorigenesis. Clin Cancer Res 13 (2007) 1107-1114
118. Wang Y., Jatkoe T., Zhang Y., et al. Gene expression profiles and molecular markers to predict recurrence of Dukes'B colon cancer. J Clin Oncol 22 (2004) 1564-1571
119. Sansom O.J., Reed K.R., Hayes A.J., et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18 (2004) 1385-1390
120. Cheah P.Y., Eu K.W., and Seow-Choen F. Update of genetics in colorectal carcinomas: genomic instability and somatic evolution. Annals Acad Med Singapore 29 (2000) 331-336
121. Homfray T.F.R., Cottrell S.E., Ilyas M., et al. Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumors. Hum Mut 11 (1998) 114-120
122. Siber O.M., Heinimann K., Gorman P., et al. Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc Natl Acad Sci USA 99 (2002) 16910-16915
123. Konishi M., Kikuchi-Yanoshita R., Tanaka K., et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111 (1996) 307-317
124. Miyaki M., Iijima T., Kimura J., et al. Frequent mutation of β-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 59 (1999) 4506-4509
125. He X.C., Zhang J., Tong W.G., et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet 36 (2004) 1117-1121
126. van den Brink G.R. Linking pathways in colorectal cancer. Nat Genet 36 (2004) 1038-1039
127. Waite K.A., and Eng C. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Hum Mol Genet 12 (2003) 679-684
128. Planchon S.M., Waite K.A., and Eng C. The nuclear affairs of PTEN. J Cell Sci 121 (2008) 249-253
129. Mohenni H., Lin-Marq N., Buchet-Poyau K., et al. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Hum Mol Genet 14 (2005) 2209-2219
130. Lin-Marq N., Borel C., and Antonarakis S.E. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling. Mol Genet Genomics 273 (2005) 184-196
131. Jansen M., de Leng W.W.J., Baas A.F., et al. Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut 55 (2006) 1-5
132. Clevers H. Stem cells, asymmetric division and cancer. Nat Genet 37 (2005) 1027-1028
133. Uronis J.M., Herfarth H.H., Rubinas T.C., Bissahoyo A.C., Hanlon K., and Threadgill D.W. Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage. Cancer Res 67 (2007) 11594-11600
134. Fogt F., Urbanski S.J., Sanders M.E., et al. Distinction between dysplasia associated lesion or mass (DALM) and adenoma in patients with ulcertive colitis. Hum Pathol 31 (2000) 288-291
135. Chung G.G., Provost E., Kielhorn E.P., Charette L.A., Smith B.L., and Rimm D.L. Tissue microarray anlaysis of beta-catenin in colorectal cancer shows nuclear phosphobeta-catenin is associated with a better prognosis. Clin Cancer Res 7 (2001) 4013-4020
136. Cheah P.Y., Choo P.H., Yao J., Eu K.W., and Seow-Choen F. A survival stratification model of human colorectal carcinomas with β-catenin and p27kip1. Cancer 95 (2002) 2479-2486
137. Baldus S.E., Monig S.P., Huxel S., et al. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 10 (2004) 2790-2796
138. Lynch H.T., Boland C.R., Rodriguez-Bigas M.A., Amos C., Lynch J.F., and Lynch P.M. Who should be sent for genetic testing in hereditary nonpolyposis colorectal cancer syndromes?. J Clin Oncol 25 (2007) 3534-3542
139. Vasen H.F., Moslein G., Alonso A., et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44 (2007) 353-362
140. Vasen H.F., Moslein G., Alonso A., et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57 (2008) 704-713